Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Lichen Planus in siblings may be influenced by genetics and environment.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Trichoscopy is essential for diagnosing and treating autoimmune cicatricial alopecia early.

The woman has a scalp condition causing hair loss.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.